DBV Technologies DBVT
NASDAQ DBVT
$13.52 -0.18 (-1.31%)
As of: Sep 4, 2026 · 2:20 PM EDT

DBV Technologies (DBVT) EBITDA (2020 - 2026)

DBV Technologies (DBVT) posted EBITDA of -$50.6 million for Q2 2026, down 5.64% sequentially from -$47.9 million in Q1 2026, and down 23.11% YoY from -$65.8 million in Q2 2025.

Analysis

DBV Technologies (DBVT) EBITDA (2020 - 2026) Analysis & Trends

DBV Technologies has reported EBITDA for 7 years, with the latest figure at -$50.6 million in Q2 2026.

  • Quarterly EBITDA fell 23.11% year-over-year to -$50.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$177.8 million (down 45.89% YoY) and the FY2025 annual result came in at -$147.1 million, down 26.13% from the prior year.
  • EBITDA slipped to -$50.6 million in Q2 2026 per DBVT's latest filing, from -$47.9 million in the prior quarter.
  • Over five years, EBITDA peaked at -$11.9 million in Q4 2023 and troughed at -$50.6 million in Q2 2026.
  • A 5-year average of -$29.7 million and a median of -$27.6 million in 2024 frame the typical range for EBITDA.
  • The sharpest annual moves came in 2022 and 2023: EBITDA slumped 182.09% in 2022, then soared 68.65% in 2023.
  • Over 5 years, EBITDA stood at -$38.0 million in 2022, then surged by 68.65% to -$11.9 million in 2023, then plunged by 100.18% to -$23.9 million in 2024, then slumped by 88.81% to -$45.1 million in 2025, then declined by 12.32% to -$50.6 million in 2026.
  • According to Business Quant data, EBITDA over the past three periods registered -$50.6 million, -$47.9 million, and -$45.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Vertex Pharmaceuticals 138.92 Bn 131.07 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 85.55 Bn 77.56 Bn 3.93 Bn 1.29 Bn
3 Argenx Se 63.55 Bn 58.37 Bn 1.37 Bn 493.00 Mn
4 Moderna 58.26 Bn 53.13 Bn 52.00 Mn -815.00 Mn
5 Revolution Medicines 44.08 Bn 44.08 Bn - -505.13 Mn
6 BeOne Medicines 39.98 Bn 34.89 Bn 1.53 Bn 325.05 Mn
7 Alnylam Pharmaceuticals 35.32 Bn 32.01 Bn 992.69 Mn 231.44 Mn
8 Royalty Pharma 28.42 Bn 27.59 Bn - 133.12 Mn
9 Insmed 27.41 Bn 26.25 Bn 358.27 Mn -1.55 Mn
10 DBV Technologies 5.88 Bn 5.70 Bn - -50.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -50.60 Mn
Mar 31, 2026 -47.90 Mn
Dec 31, 2025 -45.05 Mn
Sep 30, 2025 -34.28 Mn
Jun 30, 2025 -41.10 Mn
Mar 31, 2025 -26.60 Mn
Dec 31, 2024 -23.86 Mn
Sep 30, 2024 -30.33 Mn
Jun 30, 2024 -33.84 Mn
Mar 31, 2024 -28.56 Mn
Dec 31, 2023 -11.92 Mn
Sep 30, 2023 -18.27 Mn
Jun 30, 2023 -25.08 Mn
Mar 31, 2023 -21.17 Mn
Dec 31, 2022 -38.02 Mn
Sep 30, 2022 -18.02 Mn
Jun 30, 2022 -23.82 Mn
Mar 31, 2022 -16.77 Mn
Dec 31, 2021 -13.48 Mn
Sep 30, 2021 -24.37 Mn